chartexchange

BHVN
Biohaven Ltd.
stockNYSE

At CloseNov 18, 2026 3:59:56 PM EST
12.90USD-2.530%(-0.34)2,323,927
Pre-marketNov 18, 2026 8:41:30 AM EST
13.25USD+0.076%(+0.01)
After-hoursNov 18, 2026 4:10:30 PM EST
12.90USD-0.039%(-0.01)
Loading…
Loading…
Healthcare
Biotechnology
HQ
New Haven, CT, USA
Previous Close
$13.24
Beta
1.36
52-Week High
$18.24 2026-08-26
52-Week Low
$8.03 2026-03-30
SMA 50
$13.41
SMA 200
$12.35
Avg. Vol 10D
2.20M
Avg. Vol 30D
3.19M
Avg. Vol 90D
2.84M
Relative Vol
0.73
151.06M
128.57M
15,012,928
0.4300%
10,000,000
BHVN Profile

Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.

BHVN Performance
PeriodPriceDateChangeBeta
1W14.072026-11-12-8.24%-1.107
1M11.352026-10-19+13.74%1.323
3M14.142026-08-19-8.70%1.884
6M8.392026-05-19+53.87%1.286
1Y9.462025-11-19+36.47%1.356
2Y46.302024-11-19-72.12%—
5Y113.752021-11-19-88.65%1.039
BHVN Stock Summary

Biohaven Ltd. (NYSE:BHVN) stock price today is $12.91, and today's volume is 2,323,927. BHVN is down 2.492% today. The 30 day average volume is 3.19M. BHVN market cap is $1.95B with 151.06M shares outstanding.